![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » US COURT FAVOURS RANBAXY IN LIPITOR PATENT CASE
US COURT FAVOURS RANBAXY IN LIPITOR PATENT CASE
Country's biggest drug maker, Ranbaxy Laboratories Ltd on Thursday said a US Appeals Court has ruled in its favour in the patent infringement case with Pfizer for cholesterol-lowering drug Atorvastatin (Lipitor).
The Economic Times (http://economictimes.indiatimes.com/articleshow/1844892.cms)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct